Revenue | ₹29.65Cr |
Net Profits | ₹0.77Cr |
Net Profit Margins | 2.60% |
Godavari Drugs Ltd’s revenue fell -31.3% since last year same period to ₹29.65Cr in the Q3 2024-2025. On a quarterly growth basis, Godavari Drugs Ltd has generated 13.6% jump in its revenue since last 3-months.
Godavari Drugs Ltd’s net profit fell -36.89% since last year same period to ₹0.77Cr in the Q3 2024-2025. On a quarterly growth basis, Godavari Drugs Ltd has generated -29.36% fall in its net profits since last 3-months.
Godavari Drugs Ltd’s net profit margin fell -8.13% since last year same period to 2.60% in the Q3 2024-2025. On a quarterly growth basis, Godavari Drugs Ltd has generated -37.82% fall in its net profit margins since last 3-months.
The revenue for Godavari Drugs Ltd in the Q3 results 2024 was ₹29.65Cr.
The net profit for Godavari Drugs Ltd in the Q3 results 2024 was ₹0.77Cr.
The net profit margin for Godavari Drugs Ltd in the Q3 results 2024 was 2.60%.
The revenue for Godavari Drugs Ltd in the Q3 results 2023 was ₹43.16Cr.
The net profit for Godavari Drugs Ltd in the Q3 results 2023 was ₹1.22Cr.
The net profit margin for Godavari Drugs Ltd in the Q3 results 2023 was 2.83%.